1Schder A, Huwyler J. Drug transport to brain with targeted liposomes [ J ]. Neuro Rx, 2005 , 2 ( 1 ) : 99-107.
2Kim NH, Park HM, Chung SY, et al. Immunoliposomes car- rying plasmid DNA:preparation and characterization [J].Arch Pharm, Res , 2004,27 ( 12 ) : 1263.
3Zhang Y , Calon F , Zhu C , et al. Intravenous nonviral gene therapy causes normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism [J].Hum Gene Ther,2003 , 14(1): 1-12.
5Tsutomu Y, Kazuo M, Motoharu I, et al. Prolongation of Li- posome Circulation Time by Various Drivatives of Polyethylen- eglycols[J].Biol Pharm Bull, 1996, 19(10): 1347.
6Check E. Gene-therapy trials to restart following cancer risk review [ J ]. Nature, 2005 , 434 ( 7030 ) : 127.
7Zhao H , Wang R , Wang F , et al. Preparation of brain tar- geted immunoliposomes [ J ]. Acta Pharm Sin , 2009 , 44 ( 11 ) : 1285-129.
8Naoto Ok , Yoshihiro T, Chieko K, et al. Liposomal Arg-Gly- Asp analogs effectively inhibit metastic B16 melanoma colo- nization in routine lungs [ J ]. Life sciences , 1996 , 58 ( 24 ) : 2263.
